RejuveNAD

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice

2.2 Label elements

This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % 6/12/2024 (Revision date) EN (English) 2/9 Reference number: xxxx-XXX

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP]Mixtures/Substances: SDS EU > 2015: According to Regulation (EU) 2015/830, 2020/878 (REACH Annex II) Not classified Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.